Vedolizumab
(Anti-human α4β7 mAb, human IgG1-Kappa; MLN-0002)
Catalog No.: PC-Ab1072Not For Human Use, Lab Use Only.
Vedolizumab (MLN-0002) is a humanized monoclonal antibody, which acts against α 4 β 7 integrin heterodimer and blocks the interaction of α4β7 integrin with mucosal address in cell adhesion molecule-1 (MAdCAM-1). Vedolizumab inhibits the migration of memory T-lymphocytes across the endothelium into inflamed gastrointestinal (GI) parenchymal tissue, impairs the migration of gut-homing lymphocytes into the mucosa, thereby acting as a gut-selective anti-lymphocyte-trafficking immunomodulator..
Vedolizumab (MLN-0002) is a humanized monoclonal antibody, which acts against α 4 β 7 integrin heterodimer and blocks the interaction of α4β7 integrin with mucosal address in cell adhesion molecule-1 (MAdCAM-1). Vedolizumab inhibits the migration of memory T-lymphocytes across the endothelium into inflamed gastrointestinal (GI) parenchymal tissue, impairs the migration of gut-homing lymphocytes into the mucosa, thereby acting as a gut-selective anti-lymphocyte-trafficking immunomodulator.
Physicochemical Properties
M.Wt
Formula
Human IgG1-Kappa
Appearance
Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility
PBS, pH 7.0
Contains no stabilizers or preservatives
